Youn H Kim

Youn H Kim

UNVERIFIED PROFILE

Are you Youn H Kim?   Register this Author

Register author
Youn H Kim

Youn H Kim

Publications by authors named "Youn H Kim"

Are you Youn H Kim?   Register this Author

96Publications

-Reads

Variability in the Expression of Immunohistochemical Markers: Implications for Biomarker Interpretation in Cutaneous T-Cell Lymphoma.

J Invest Dermatol 2018 May 14;138(5):1204-1206. Epub 2017 Dec 14.

Department of Dermatology, Stanford University School of Medicine, Palo Alto, California, USA; Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, California, USA. Electronic address:

View Article
May 2018

Brentuximab vedotin: targeting CD30 as standard in CTCL.

Oncotarget 2018 Feb 10;9(15):11887-11888. Epub 2018 Feb 10.

H. Miles Prince: Division of Cancer Medicine, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology and Epworth Healthcare, The University of Melbourne, Victoria, Australia.

View Article
February 2018

Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.

Cancer Cell 2017 07 15;32(1):27-41.e4. Epub 2017 Jun 15.

Center for Personal Dynamic Regulomes and Program in Epithelial Biology, Stanford University School of Medicine, CCSR 2155c, 269 Campus Drive, Stanford, CA 94305-5168, USA; Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address:

View Article
July 2017

An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone.

JAAD Case Rep 2017 Jul 15;3(4):276-279. Epub 2017 Jun 15.

Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article
July 2017

Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.

JAAD Case Rep 2017 Jul 19;3(4):310-315. Epub 2017 Jul 19.

Department of Dermatology, Stanford Cancer Center, Stanford Hospital and Clinics, Stanford, California, USA.

View Article
July 2017

Cutaneous T-Cell Lymphomas.

JAMA Dermatol 2017 Jun;153(6):620

View Article
June 2017

Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome.

J Neurooncol 2017 05 7;132(3):439-446. Epub 2017 Mar 7.

Division of Neuro-Oncology, Department of Neurology and Neurological Sciences, Stanford University, 875 Blake Wilbur Drive, CC 2221, Stanford, CA, 94305-5826, USA.

View Article
May 2017

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

J Natl Compr Canc Netw 2017 03;15(3):293-311

From The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Women's Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Moffitt Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fred & Pamela Buffett Cancer Center; and National Comprehensive Cancer Network.

View Article
March 2017

Zosteriform Mycosis Fungoides: A New Clinical Presentation With a Dermatomal Distribution.

Am J Dermatopathol 2017 Feb;39(2):e17-e18

*Department of Dermatology, Stanford University School of Medicine, Redwood City, CA; and †Department of Pathology, Stanford University School of Medicine, Stanford, CA.

View Article
February 2017

Neurotropic Gamma-Delta T-Cell Lymphoma With CD30-Positive Lymphoid Infiltrates.

Am J Dermatopathol 2016 Sep;38(9):e133-6

Departments of *Pathology, and †Dermatology, Stanford Medicine, Stanford, CA.

View Article
September 2016

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

J Natl Compr Canc Netw 2016 09;14(9):1067-79

From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Women's Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Moffitt Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article
September 2016

Useful Parameters for Distinguishing Subcutaneous Panniculitis-like T-Cell Lymphoma From Lupus Erythematosus Panniculitis.

Am J Surg Pathol 2016 06;40(6):745-54

Departments of *Pathology †Dermatology, Stanford University School of Medicine, Stanford, CA.

View Article
June 2016

Experimental treatment strategies in primary cutaneous T-cell lymphomas.

Curr Opin Oncol 2016 Mar;28(2):166-71

Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.

View Article
March 2016

Subcutaneous panniculitis-like T-cell lymphoma: Pediatric case series demonstrating heterogeneous presentation and option for watchful waiting.

Pediatr Blood Cancer 2015 Nov 6;62(11):2025-8. Epub 2015 Jul 6.

Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

View Article
November 2015

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.

J Clin Oncol 2015 Nov 20;33(32):3750-8. Epub 2015 Jul 20.

Youn H. Kim, Mahkam Tavallaee, Uma Sundram, Shufeng Li, Sima Rozati, Seema Nagpal, Michael Krathen, Sunil Reddy, Richard T. Hoppe, Annie Nguyen-Lin, Wen-Kai Weng, Randall Armstrong, and Ranjana H. Advani, Stanford University, Stanford, CA; Katrin A. Salva and Gary S. Wood, University of Wisconsin and William S. Middleton Memorial Veterans Hospital, Madison, WI; and Melissa Pulitzer and Steven M. Horwitz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article
November 2015

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

J Clin Oncol 2015 Nov 5;33(32):3766-73. Epub 2015 Oct 5.

Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa,

View Article
November 2015

Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.

Am J Dermatopathol 2015 Oct;37(10):767-70

Departments of *Pathology, †Radiation Oncology, and ‡Dermatology, Stanford University School of Medicine, Stanford, CA.

View Article
October 2015

Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.

Hum Pathol 2015 Sep 10;46(9):1382-9. Epub 2015 Jun 10.

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305. Electronic address:

View Article
September 2015

Primary Cutaneous Gamma-Delta T-Cell Lymphoproliferative Disorder in a 3-Year-Old Boy.

Am J Dermatopathol 2015 Jul;37(7):567-9

Departments of *Pathology, †Pediatric Hematology and Oncology, and ‡Dermatology, Stanford University Medical Center, Stanford, CA.

View Article
July 2015

Individuality and variation of personal regulomes in primary human T cells.

Cell Syst 2015 Jul;1(1):51-61

Howard Hughes Medical Institute and Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA 94305.

View Article
July 2015

Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.

Am J Surg Pathol 2014 Sep;38(9):1203-11

Departments of *Pathology #Dermatology, Stanford University School of Medicine, Stanford †UCLA Medical Center, Los Angeles ‡San Diego Pathologists Medical Group, San Diego, CA §Department of Dermatology, Mayo Clinic, Jacksonville, FL ∥Department of Pathology, Massachusetts General Hospital, Boston, MA ¶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

View Article
September 2014

Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.

JAMA Dermatol 2014 Jul;150(7):709-15

Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California6Health Sciences, Exponent, Inc, Menlo Park, California.

View Article
July 2014

Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome.

Blood 2014 Feb 11;123(8):1159-66. Epub 2013 Dec 11.

Department of Medicine/Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY;

View Article
February 2014

Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.

Sci Transl Med 2013 Dec;5(214):214ra171

Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article
December 2013

Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient.

Am J Dermatopathol 2013 Feb;35(1):11-8

Department of Pathology, Stanford University Medical Center, Stanford, CA 94305-5324, USA.

View Article
February 2013

Romidepsin is effective in subcutaneous panniculitis-like T-cell lymphoma.

J Clin Oncol 2012 Aug 2;30(24):e221-5. Epub 2012 Jul 2.

Stanford University School of Medicine, CA, USA.

View Article
August 2012

The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.

Am J Hematol 2012 Apr 24;87(4):354-60. Epub 2012 Feb 24.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104 , USA.

View Article
April 2012

Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.

Clin Lymphoma Myeloma Leuk 2012 Feb 15;12(1):20-5. Epub 2011 Oct 15.

Department of Medicine, New York Presbyterian-Weil Cornell Medical Center, 1275 York Avenue, New York, NY 10021, USA.

View Article
February 2012

The frequency of dual TCR-PCR clonality in granulomatous disorders.

J Cutan Pathol 2011 Sep 7;38(9):704-9. Epub 2011 Jun 7.

Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA.

View Article
September 2011

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma.

J Am Acad Dermatol 2010 Dec;63(6):975-83

Department of Dermatology, Multidisciplinary Cutaneous Lymphoma Program, Stanford Cancer Center, Stanford, California 94305, USA.

View Article
December 2010

Multidisciplinary care in the management of patients with cutaneous lymphoma: a perspective.

Authors:
Youn H Kim

Clin Lymphoma Myeloma Leuk 2010 Sep;10 Suppl 2:S106-8

Multidisciplinary Cutaneous Lymphoma Program, Stanford Cancer Center, CA.

View Article
September 2010

A phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders.

Clin Cancer Res 2009 Oct 29;15(19):6217-24. Epub 2009 Sep 29.

Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4003, USA.

View Article
October 2009

A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome.

Biol Blood Marrow Transplant 2009 Aug;15(8):982-90

Division of Dermatology, Washington University, St. Louis, Missouri 63110, USA.

View Article
August 2009

Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.

J Am Acad Dermatol 2008 Dec 24;59(6):953-7. Epub 2008 Sep 24.

Multidisciplinary Cutaneous Lymphoma Program, Stanford Comprehensive Cancer Center, Stanford, California 94305, USA.

View Article
December 2008

Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease.

J Am Acad Dermatol 2008 Oct 11;59(4):706-12. Epub 2008 Jun 11.

Department of Dermatology, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article
October 2008

Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.

Am J Dermatopathol 2008 Oct;30(5):425-30

Department of Dermatology, Stanford University Medical Center, Stanford, CA 94305, USA.

View Article
October 2008

Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach.

J Natl Compr Canc Netw 2008 Apr;6(4):436-42

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article
April 2008

T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides.

J Am Acad Dermatol 2007 Nov 23;57(5):782-90. Epub 2007 Jul 23.

Department of Pathology, Stanford University, Stanford, California 94035, USA.

View Article
November 2007

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.

Blood 2007 Jun 20;109(11):4655-62. Epub 2007 Feb 20.

Multidisciplinary Cutaneous Lymphoma Program, Stanford Comprehensive Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article
June 2007

Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology.

J Cutan Pathol 2006 Sep;33 Suppl 2:6-11

Department of Pathology, Stanford University Medical Center, Stanford, California 94305-5324, USA.

View Article
September 2006

Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.

Arch Dermatol 2004 Sep;140(9):1140-6

Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article
September 2004

Management with topical nitrogen mustard in mycosis fungoides.

Authors:
Youn H Kim

Dermatol Ther 2003 ;16(4):288-98

Department of Dermatology, Multidisciplinary Cutaneous Lymphoma Group, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article
May 2004

CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.

J Am Acad Dermatol 2003 Dec;49(6):1049-58

Department of Dermatology, Stanford University, 900 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article
December 2003

Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma.

Hematol Oncol Clin North Am 2003 Dec;17(6):1485-507

Department of Dermatology and Medicine, Boston University School of Medicine, 720 Harrison Avenue, DOB 801A, Boston, MA 02118, USA.

View Article
December 2003

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.

Arch Dermatol 2003 Jul;139(7):857-66

Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article
July 2003

Gene expression profiles of cutaneous B cell lymphoma.

J Invest Dermatol 2003 May;120(5):865-70

Department of Pathology, Division of Medical Oncology, Stanford University Medical Center, Stanford, California 94305, USA.

View Article
May 2003

Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.

Arch Dermatol 2003 Feb;139(2):165-73

Department of Dermatology, Stanford University School of Medicine, 900 Blake Wilbur Dr, No. W0069, Stanford, CA 94305, USA.

View Article
February 2003

Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea.

J Cutan Pathol 2002 Mar;29(3):135-41

Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.

View Article
March 2002